ENDOTHELIUM-DEPENDENT RELAXATIONS MEDIATED BY INDUCIBLE B-1 AND CONSTITUTIVE B-2 KININ RECEPTORS IN THE BOVINE ISOLATED CORONARY-ARTERY

被引:46
作者
DRUMMOND, GR [1 ]
COCKS, TM [1 ]
机构
[1] UNIV MELBOURNE,DEPT PHARMACOL,PARKVILLE,VIC 3052,AUSTRALIA
关键词
BRADYKININ; DES-ARG(9)-BRADYKININ; B-1; B-2 KININ RECEPTORS; DES-ARG(9)-[LEU(8)]-BRADYKININ; HOE-140; ENDOTHELIUM; CYCLOHEXIMIDE; ACTINOMYCIN D; NITRIC OXIDE; BOVINE CORONARY ARTERY;
D O I
10.1111/j.1476-5381.1995.tb15098.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Rings of bovine left anterior descending coronary artery (LAD) were contracted with the thromboxane A(2)-mimetic, U46619 (1-30 nM), to approximately 40% of their maximum contraction to 125 mM KCl Krebs solution (KPSSmax) for comparison of responses to the B-1 and B-2 kinin receptor agonists, des-Arg(9)-bradykinin (des-Arg(9)-BK) and bradykinin (BK), respectively. Relaxation responses were normalized as percentages of the initial U46619-induced contraction level, while contractile responses were expressed as percentages of KPSSmax. 2 After 6 h of in vitro incubation in Krebs solution at 37 degrees C, des-Arg(9)-BK ((p)EC(50), 8.00 +/- 0.08; maximum response (R(max)) 93.9 +/- 1.9%) and BK ((p)EC(50), 9.75 +/- 0.07; R(max), 100.1 +/- 0.7%) caused endothelium-dependent relaxations in precontracted rings of bovine LAD which were competitively and selectively antagonized by the B-1 receptor antagonist, des-Arg(9)-[Leu(8)]-BK (pA(2), 6.27 +/- 0.11) and the B-2 receptor antagonist Hoe-140 (pA(2), 9.63 +/- 0.14), respectively. 3 At 3 h of in vitro incubation, the sensitivity ((p)EC(50), 7.45 +/- 0.10) and R(max) (84.6 +/- 3.3%) to des-Arg(9)-BK were significantly less than those obtained in the same tissues at 6 h ((p)EC(5)0, 7.94 +/- 0.06; R(max), 91.4 +/- 2.5%), whereas endothelium-dependent relaxations to BK and ACh were unaffected by incubation time. 4 Relaxation responses to des-Arg(9)-BK, but not BK, at both 3 h and 6 h were significantly attenuated by the protein synthesis inhibitors, cycloheximide (30 and 100 mu M) and actinomycin D (2 mu M). 5 At 6 h, the nitric oxide (NO) synthase inhibitor, N-G-nitro-L-arginine (L-NOARG, 100 mu M), caused a significant 2 fold decrease in (p)EC(50) (9.58 +/- 0.03) but had no effect on R(max) for BK. For des-Arg(9)-BK, L-NOARG (100 mu M) caused a marked and significant decrease in both the (p)EC(50) and R(max) and revealed contractions to low concentrations of des-Arg(9)-BK. In both cases, L-NOARG inhibition was reversed in the presence of L-arginine (10 mM). 6 At 6 h, removal of the endothelium abolished relaxation responses to des-Arg(9)-BK and BK, and for des-Arg(9)-BK, but not BK, unmasked concentration-dependent contractions ((p)EC(50), 7.57 +/- 0.09; R(max), 83.4 +/- 9.1%). The sensitivity of contractions to des-Arg(9)-BK increased slightly from 3 h ((p)EC(50), 7.37 +/- 0.08) to 6 h ((p)EC(50), 7.62 +/- 0.12) of in vitro incubation; however, there was a small but significant depression in the maximum response over this time (R(max), 126.8 +/- 8.5% and 103.3 +/- 8.6% for 3 h and 6 h of incubation respectively). 7 In conclusion, the bovine LAD contains inducible B-1 and constitutive B-2 endothelial cell kinin receptors, both of which mediate endothelium-dependent relaxation partly via the release of NO. B-1 receptors were also present on the smooth muscle layer of the bovine LAD.
引用
收藏
页码:2473 / 2481
页数:9
相关论文
共 41 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   ACE INHIBITORS ARE ENDOTHELIUM DEPENDENT VASODILATORS OF CORONARY-ARTERIES DURING SUBMAXIMAL STIMULATION WITH BRADYKININ [J].
AUCHSCHWELK, W ;
BOSSALLER, C ;
CLAUS, M ;
GRAF, K ;
GRAFE, M ;
FLECK, E .
CARDIOVASCULAR RESEARCH, 1993, 27 (02) :312-317
[3]   BINDING OF [H-3]-LABELED DES-ARG9-BK TO RABBIT ANTERIOR MESENTERIC VEIN [J].
BARABE, J ;
BABIUK, C ;
REGOLI, D .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (12) :1551-1555
[4]   EFFECTS OF BRADYKININ IN THE RAT ISOLATED PERFUSED HEART - ROLE OF KININ RECEPTORS AND ENDOTHELIUM-DERIVED RELAXING FACTOR [J].
BAYDOUN, AR ;
WOODWARD, B .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (03) :1829-1833
[5]   INTERACTION OF BRADYKININ AND DES-ARG9-BRADYKININ WITH ISOLATED PIG CORONARY-ARTERIES - MECHANICAL AND ELECTROPHYSIOLOGICAL EVENTS [J].
BENY, JL ;
BRUNET, P ;
HUGGEL, H .
REGULATORY PEPTIDES, 1987, 17 (04) :181-190
[6]   STUDIES ON THE INDUCTION OF PHARMACOLOGICAL RESPONSES TO DES-ARG9-BRADYKININ INVITRO AND INVIVO [J].
BOUTHILLIER, J ;
DEBLOIS, D ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (02) :257-264
[7]   ROLE OF ENDOTHELIAL-CELLS IN RELAXATION OF ISOLATED ARTERIES BY BRADYKININ [J].
CHERRY, PD ;
FURCHGOTT, RF ;
ZAWADZKI, JV ;
JOTHIANANDAN, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06) :2106-2110
[8]   RELAXATION OF ISOLATED MESENTERIC-ARTERIES BY DES-ARG9-BRADYKININ STIMULATION OF B1-RECEPTORS [J].
CHURCHILL, L ;
WARD, PE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 130 (1-2) :11-18
[9]  
COWAN CL, 1993, J PHARMACOL EXP THER, V266, P1482
[10]   PHARMACOLOGICAL MODULATION OF THE UP-REGULATED RESPONSES TO DES-ARG9-BRADYKININ INVIVO AND INVITRO [J].
DEBLOIS, D ;
BOUTHILLIER, J ;
MARCEAU, F .
IMMUNOPHARMACOLOGY, 1989, 17 (03) :187-198